What Happens If Back Injections Don’t Work?

When back injections fail, the path forward usually involves figuring out why they didn’t work and then choosing from a range of alternatives that includes different injection techniques, nerve-targeting procedures, medication adjustments, physical rehabilitation, and sometimes surgery. The critical point most people miss is that a failed injection is itself useful information. It can reveal that the original diagnosis was incomplete, that the pain generator is somewhere other than where the needle went, or that the nervous system has changed in ways that a local steroid can’t fix. Rather than a dead end, a failed injection is often a diagnostic fork in the road.

Why Back Injections Fail in the First Place

Epidural steroid injections work by delivering anti-inflammatory medication near compressed or irritated nerve roots. When the pain is genuinely caused by a herniated disc pressing on a specific nerve, and that nerve is the one being bathed in steroid, results tend to be good. But several things can go wrong with that chain of assumptions.

The anatomy of the herniation itself matters. A comprehensive review of studies on transforaminal epidural steroid injections found that disc location, the degree of nerve compression, and even the technical execution of the injection all influenced outcomes. Mild nerve compression and certain clinical exam findings correlated with better results, while severe compression and challenging anatomy worked against success.¹ In other words, the injection is not equally suited to every type of disc problem. A large central herniation and a small lateral one are different targets, and the steroid may reach one more effectively than the other.

Then there is the question of whether the disc is really the problem at all. Many people have disc bulges and herniations on MRI that produce no symptoms. When a clinician sees an abnormal disc and assumes it is causing the pain, the injection is aimed at a bystander rather than the culprit. This misattribution is more common than most patients realize, and it is one of the most important reasons injections fail.

When the Pain Is Coming from Somewhere Else

The sacroiliac joint, which connects your lower spine to your pelvis, is a frequent source of pain that gets mistaken for disc-related sciatica. Research on patients with imaging-confirmed lumbar disc herniations found that sacroiliac joint dysfunction was common enough to recommend manual examination of that joint in anyone with low back and leg symptoms, regardless of what the MRI showed. Failing to identify this dysfunction could lead to unnecessary disc-focused procedures.² A separate study reinforced this, concluding that clinicians should look beyond the intervertebral disc to the sacroiliac joint to avoid aggressive treatments that won’t help.³

If your epidural injection didn’t help, this is one of the first questions a good pain specialist will revisit. Sacroiliac joint pain often produces a deep ache in the buttock that can radiate down the leg, mimicking sciatica closely enough to fool both patients and doctors. A diagnostic block of the sacroiliac joint, where a small amount of local anesthetic is injected directly into it, can sort this out fairly quickly. If the pain disappears temporarily, you have your answer and can pursue treatment aimed at the right structure.

Facet joints, the small paired joints along the back of the spine, are another common pain generator that epidural injections won’t address. Facet-mediated pain tends to worsen with extension and twisting rather than sitting and bending. Diagnostic medial branch blocks, which numb the tiny nerves supplying the facet joints, can confirm or rule out this source.

The Role of Central Sensitization

Sometimes the problem isn’t where the needle goes but how the nervous system is processing pain signals. In chronic pain, the spinal cord and brain can become “wound up,” amplifying normal signals into intense pain even after the original tissue injury has partially or fully healed. This is sometimes called central sensitization, and it is a real physiological change, not a psychological one.

A study on patients receiving transforaminal epidural steroid injections for chronic lumbar radiculopathy found that those with signs of central sensitization had significantly worse pain scores at every follow-up point compared to patients without it. Central sensitization also worsened disability and mental health outcomes after the procedure.⁴ This finding makes intuitive sense: if the volume knob in your nervous system is turned all the way up, quieting one source of inflammation at the periphery won’t be enough. These patients typically need a broader treatment strategy that targets the nervous system itself, through medications that calm nerve activity, graded exercise, and sometimes psychological approaches like cognitive behavioral therapy for pain.

Is It Too Soon to Call the Injection a Failure?

Before concluding that an injection didn’t work, it is worth considering timing. A prospective study tracking patients after musculoskeletal corticosteroid injections found that about one in five experienced a temporary pain flare afterward. Younger patients were more likely to have flares. Among those who eventually got relief, roughly 60% improved within three days, and over 93% had relief within a week.⁵ If you are only two or three days out from your injection and feeling worse, that may be a flare rather than a sign the injection failed. Most pain specialists recommend giving it at least a full week, and sometimes two, before drawing conclusions.

That said, if you are four to six weeks out and have seen no meaningful improvement, the injection has had its chance. The steroid effect peaks within the first couple of weeks and then gradually wanes. A complete lack of response at that point warrants a change in strategy.

Trying a Different Injection Technique

Not all epidural injections are the same. The two most common routes are transforaminal, where the needle enters near the nerve root as it exits the spine, and interlaminar, where it enters from the back between the vertebral arches. If you had one type and it didn’t help, switching to the other is a reasonable step.

The evidence on which route is better is genuinely mixed. One study found no significant difference in pain or disability scores between the two approaches at one, three, or six months.⁶ However, a registry-based study found that transforaminal injections were about three times more likely to achieve at least a 50% reduction in leg pain compared to interlaminar injections, with the advantage persisting after adjusting for other variables.⁷ The practical takeaway is that if you had an interlaminar injection and it failed, a transforaminal approach targeting the specific nerve root may be worth trying, especially if leg pain is your dominant symptom.

Electromyography, which measures the electrical activity of muscles, can also help guide next steps. One prospective study found that EMG findings improved after epidural steroid injections and that the improvement in certain electrical patterns correlated with better pain and functional outcomes. Patients with disc herniation had better clinical and electromyographic results than patients with spinal stenosis.⁸ If an EMG shows worsening nerve function despite injections, that may tip the balance toward surgical evaluation.

Medications That Target Nerve Pain

When injections fail and surgery isn’t indicated or desired, oral medications become a central pillar of management. Nerve pain responds to a different set of drugs than typical muscle or joint pain. Standard anti-inflammatories like ibuprofen often do very little for radicular pain because the problem involves irritated nerve tissue rather than simple inflammation.

First-line medications for neuropathic pain include certain antidepressants (tricyclics and serotonin-noradrenaline reuptake inhibitors like duloxetine) and nerve-calming drugs like gabapentin and pregabalin. These work by modulating how the nervous system processes pain signals. Topical lidocaine patches can help for localized areas. Stronger options like tramadol exist as third-line treatments but carry risks of dependence and side effects that require careful weighing.⁹ These medications are not just painkillers in the traditional sense; they address the nerve-level dysfunction that injections were trying to treat from the outside.

Physical Therapy After a Failed Injection

Physical therapy is often recommended alongside injections, but many patients skip or minimize it when the injection itself provides relief. When the injection doesn’t work, structured rehabilitation becomes even more important. A randomized trial in patients with lumbar spinal stenosis compared epidural steroid injection alone to injection combined with physical therapy. While both groups improved significantly in disability measures at 10 weeks and one year, the group that received physical therapy on top of the injection showed better emotional well-being and general health perception at the 10-week mark.¹⁰

The improvements in emotional function and general health are worth noting because chronic back pain is never purely a tissue problem. How you move, how confident you feel moving, and whether you believe movement is safe all influence pain levels. A good physical therapist will work on mobility, core stability, and gradually increasing your tolerance for activities that have become frightening or painful. For patients whose injections have failed and who have signs of central sensitization, this graded exposure approach is especially valuable.

Radiofrequency Ablation for Facet and Sacroiliac Pain

If diagnostic blocks confirm that facet joints or the sacroiliac joint are driving your pain, radiofrequency ablation is often the next step. The procedure uses heat delivered through a needle tip to disable the small nerves that transmit pain from these joints. The effect typically lasts months to over a year, since the treated nerves eventually regenerate.

A study examining balance in patients undergoing medial branch blocks and radiofrequency ablation for facet-related spinal pain found that the risk of developing significant balance problems after the procedure was low for both cervical and lumbar treatments, with one notable exception at the very top of the cervical spine. Patients showed sensory adaptation rather than worsening balance after the procedure.¹¹ This is relevant because some patients worry that ablating nerves along the spine will affect coordination or stability, and the evidence suggests that concern is largely unfounded for most treatment levels.

Cryodenervation, which uses extreme cold rather than heat to disable the same nerves, is an emerging alternative. In a study of patients with chronic low back pain from facet joints, about 58% returned to work after lumbar facet cryodenervation, with the highest return rates among younger adults.¹² The procedure was also found to be cost-effective relative to national thresholds, making it a practical option where available.

Spinal Cord Stimulation

For patients who have exhausted conservative and minimally invasive options, or who have had back surgery that didn’t resolve their pain, spinal cord stimulation is a technology worth knowing about. It involves implanting a small device that delivers mild electrical pulses to the spinal cord, interfering with pain signals before they reach the brain. You typically go through a trial period with a temporary external device before committing to the permanent implant.

The evidence for spinal cord stimulation is strongest in patients who have persistent pain after back surgery, often called failed back surgery syndrome, especially when leg pain is the dominant complaint.¹³ A retrospective study found that it significantly reduced both back and leg pain scores at one year, and that it worked comparably well in patients aged 75 and older as in younger adults, with similar complication rates. The fact that it can be performed under local anesthesia makes it a viable option even for patients who are poor candidates for general anesthesia.¹⁴

Cost is a real concern. A systematic review found that while spinal cord stimulation increases direct medical costs compared to conventional pain management or reoperation, the improvements in quality of life offset those costs at a rate well below commonly used willingness-to-pay thresholds.¹⁵ Insurance coverage varies, but most major insurers will cover it after a successful trial period and documented failure of other treatments.

Platelet-Rich Plasma as an Alternative

Platelet-rich plasma, or PRP, is drawn from your own blood, concentrated, and injected into the painful area. It is being studied as an alternative to corticosteroid injections, and the early evidence is intriguing, particularly for patients whose steroid injections have worn off quickly or stopped working.

A meta-analysis of randomized controlled trials comparing epidural PRP to epidural steroids for prolapsed lumbar discs found a time-dependent crossover in effectiveness. At one month, steroids produced lower pain scores. But by six months, PRP delivered greater pain relief and better disability scores, while steroid-treated patients actually showed worsening pain over time.¹⁶ A systematic review looking at PRP versus corticosteroids for lumbar spondylosis and sacroiliac arthropathy similarly found that both were safe and effective, but PRP showed some advantage at longer follow-up.¹⁷

The practical limitation is that PRP is not covered by most insurance plans for spinal conditions, and a single treatment can cost several hundred dollars out of pocket. The evidence, while promising, is still accumulating, and PRP preparation methods vary between clinics, which can affect results. If you have had short-lived relief from steroid injections that keeps wearing off, PRP may be a reasonable conversation to have with your doctor, but go in with realistic expectations.

When Surgery Becomes the Discussion

Failed injections don’t automatically mean you need surgery. A meta-analysis pooling data from over 2,200 patients found that about 18% of patients who received epidural steroid injections later went on to need surgery, compared to about 20% of those who didn’t receive injections. The difference was not statistically significant for the overall group.⁵ In other words, most people who get injections do not end up on the operating table, and injections failing doesn’t change the fundamental surgical calculus much.

Surgery is most clearly indicated when there is progressive neurological loss, such as worsening weakness, foot drop, or bowel and bladder changes, or when structural imaging shows a problem that conservative care simply cannot address, like a severely narrowed spinal canal. For patients whose primary complaint is pain without neurological deterioration, the decision is more nuanced and depends heavily on the specific diagnosis, how long symptoms have persisted, and the patient’s goals and risk tolerance.

The Return-to-Work Reality

For people dealing with back injection failure in the context of a workers’ compensation claim or a physically demanding job, the numbers are sobering. A study of workers’ compensation patients with lumbar radiculopathy found that only about 10% returned to work after epidural steroid injections. The likelihood of returning dropped significantly with age, decreasing by roughly half for every additional decade of life.¹⁸ Gender and the number of injections received didn’t change the odds.

This doesn’t mean injections are useless for working-age adults, but it does mean that for people whose pain is entangled with workplace demands, return-to-work planning needs to happen alongside pain treatment rather than after it. Vocational rehabilitation, job modification, and frank conversations with employers about physical restrictions are often more determinative of whether someone gets back to work than which procedure they receive.

Virtual Reality and Emerging Approaches

For chronic nonspecific low back pain, a category that encompasses many patients whose injections have failed because there is no clear structural target to inject, some unexpected tools are showing promise. A systematic review of virtual reality interventions found significant improvements in pain reduction, fear of movement, and disability across 14 studies, with some showing benefits lasting up to 18 months after treatment.¹⁹ The mechanism likely involves retraining the brain’s movement and threat-detection systems, essentially the same central sensitization problem described earlier but approached from the other direction. Virtual reality programs for pain are FDA-cleared in some forms and increasingly available through pain clinics, though insurance coverage remains uneven. They are not a substitute for structural interventions when structural problems exist, but for the subset of patients whose pain has become a nervous system problem more than a spine problem, these tools address a gap that needles and scalpels cannot.